Abstract Details

<< Back to Schedule

9/26/2014  |   2:15 PM - 2:45 PM   |  Topical Session 3   |  Arizona

Development of Vaccines Against CMV

Vaccines against CMV are needed to prevent congenital infection as well as disease in transplant recipients. Many approaches are being taken by vaccine manufacturers, biotechnology companies and academics to develop such vaccines, including both live and killed candidates. Importantly, partial success has already been achieved to prevent acquisition of the virus in susceptible women and reduction of disease in transplant patients. However, although the path forward is clear there is much ground to be traversed before licensure of a vaccine.

Stanley Plotkin (Primary Presenter), stanley.plotkin@vaxconsult.com;
Dr. Stanley A. Plotkin is Emeritus Professor of the University of Pennsylvania. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania, Professor of Virology at the Wistar Institute and at the same time, Director of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia. He is now consultant to vaccine manufacturers and non-profit research organizations. He is a member of the Institute of Medicine of the National Academy of Sciences and the French Academy of Medicine. His bibliography includes 700 articles and he has edited several books including a textbook on vaccines. He developed the rubella vaccine now in standard use throughout the world, is codeveloper of the newly licensed pentavalent rotavirus vaccine, and has worked extensively on the development and application of other vaccines including anthrax, oral polio, rabies, varicella, and cytomegalovirus.

ASHA DISCLOSURE:

Financial - Receives Consulting fee,Honoraria for Board membership,Consulting from all major vaccine manufacturers.  

Nonfinancial - No relevant nonfinancial relationship exist.

Mark Schleiss (Co-Presenter), schleiss@umn.edu;
co-author

ASHA DISCLOSURE:

Financial - Receives Grants for Other activities from Hookipa Biotech.  

Nonfinancial - No relevant nonfinancial relationship exist.

Presentation:
200StanleyPlotkin.pdf

Handouts:
No handouts have been uploaded.